Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8976503rdf:typepubmed:Citationlld:pubmed
pubmed-article:8976503lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C0040132lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C0205615lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C0034606lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C1523987lld:lifeskim
pubmed-article:8976503lifeskim:mentionsumls-concept:C0211492lld:lifeskim
pubmed-article:8976503pubmed:issue6lld:pubmed
pubmed-article:8976503pubmed:dateCreated1997-1-23lld:pubmed
pubmed-article:8976503pubmed:abstractTextThe usefulness of the myocardial perfusion agent, Tc-99m-tetrofosmin (Myoview) in the follow-up of differentiated thyroid carcinoma was evaluated in a clinical study of 15 patients, primary treated with thyroidectomy and high-dose I-131-therapy (2960-3700 MBq). 12 with suspected recurrence and metastases and three patients without any suspicion and compared with other non-specific tracers like TI-201 and Tc-99m-sestamibi.lld:pubmed
pubmed-article:8976503pubmed:languageenglld:pubmed
pubmed-article:8976503pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:citationSubsetIMlld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8976503pubmed:statusMEDLINElld:pubmed
pubmed-article:8976503pubmed:monthDeclld:pubmed
pubmed-article:8976503pubmed:issn0029-5566lld:pubmed
pubmed-article:8976503pubmed:authorpubmed-author:LineWWlld:pubmed
pubmed-article:8976503pubmed:authorpubmed-author:GomezIIlld:pubmed
pubmed-article:8976503pubmed:authorpubmed-author:GallowitschH...lld:pubmed
pubmed-article:8976503pubmed:authorpubmed-author:MikoschPPlld:pubmed
pubmed-article:8976503pubmed:authorpubmed-author:KresnikEElld:pubmed
pubmed-article:8976503pubmed:authorpubmed-author:PipamWWlld:pubmed
pubmed-article:8976503pubmed:issnTypePrintlld:pubmed
pubmed-article:8976503pubmed:volume35lld:pubmed
pubmed-article:8976503pubmed:ownerNLMlld:pubmed
pubmed-article:8976503pubmed:authorsCompleteYlld:pubmed
pubmed-article:8976503pubmed:pagination230-5lld:pubmed
pubmed-article:8976503pubmed:dateRevised2007-1-12lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:meshHeadingpubmed-meshheading:8976503-...lld:pubmed
pubmed-article:8976503pubmed:year1996lld:pubmed
pubmed-article:8976503pubmed:articleTitleTc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.lld:pubmed
pubmed-article:8976503pubmed:affiliationDepartment of Nuclear Medicine and Special Endocrinology, LKH Klagenfurt, Austria.lld:pubmed
pubmed-article:8976503pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8976503pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8976503lld:pubmed